Kidswell Bio Corporation
Notice Regarding Recording of Special Profit (Sell-off of Investment Securities)
Plans to sell a portion of investment securities and record 221,717 thousand yen as special profit. Sale period from September 1 to 18, 2026. Special profit to be recorded in the second quarter of the fiscal year ending March 2027. Possible revision to the current consolidated earnings forecast.
Key Figures
- Investment securities sale proceeds: 221,717 千円
- Sale period: 2026年9月1日～18日
- Timing of recorded special profit: 第2四半期 2027年3月期
- Target securities: 1 listed security
AI要約
Recording of special profit and details of the sale
To strengthen our financial position and improve asset efficiency, we plan to sell a portion of held investment securities and record the gains as special profit. The target is one listed security, with sale period from September 1 to 18, 2026, and expected gains of 221,717 thousand yen.
outlook and potential revision to earnings
The gains from the sale are expected to be recognized as special profit in the second quarter of the fiscal year ending March 2027. If necessary, the company will promptly disclose any revisions to the current consolidated earnings forecast.
Kidswell Biotech Corporation
Company overview · Stock price · Financial data · All IR
